1. Orthofix earned FDA 510(k) clearance for its Rodeo telescopic nail.
2. Orthofix saw sales growth but a net loss in the first quarter of 2024.
3. Three former Orthofix executives who were fired in 2023 filed arbitration claims alleging wrongful termination.
4. Orthofix named Andres Cedron as its chief legal officer.
5. Orthofix tapped Beau Standish as its chief enabling technologies officer.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
